Welcome to LookChem.com Sign In|Join Free
  • or
1,3-Dimethylimidazolium iodide is an organic iodide salt characterized by its cationic component, 1,3-dimethylimidazolium. It is a compound with potential applications in various industries due to its unique properties.

4333-62-4

Post Buying Request

4333-62-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4333-62-4 Usage

Uses

Used in Chemical Synthesis:
1,3-Dimethylimidazolium iodide is used as a reagent for chemical synthesis processes, particularly in the formation of new organic compounds. Its cationic nature allows it to participate in various reactions, facilitating the creation of a wide range of products.
Used in Pharmaceutical Industry:
1,3-Dimethylimidazolium iodide is used as a catalyst in the pharmaceutical industry for the synthesis of various drugs and active pharmaceutical ingredients. Its ability to facilitate reactions and improve reaction rates makes it a valuable tool in the development of new medications.
Used in Electrochemical Applications:
1,3-Dimethylimidazolium iodide is used as an electrolyte in electrochemical applications, such as in batteries and fuel cells. Its ionic nature and stability contribute to improved performance and efficiency in these energy storage and conversion systems.
Used in Material Science:
1,3-Dimethylimidazolium iodide is used as a component in the development of new materials, such as ionic liquids and polymers. Its unique properties can enhance the performance of these materials, making them suitable for various applications, including energy storage, separation processes, and environmental remediation.
Used in Analytical Chemistry:
1,3-Dimethylimidazolium iodide is used as an analytical reagent in various analytical techniques, such as chromatography and spectroscopy. Its ability to interact with different compounds and improve detection sensitivity makes it a valuable tool in the analysis of complex samples.

Check Digit Verification of cas no

The CAS Registry Mumber 4333-62-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,3 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4333-62:
(6*4)+(5*3)+(4*3)+(3*3)+(2*6)+(1*2)=74
74 % 10 = 4
So 4333-62-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H9N2/c1-6-3-4-7(2)5-6/h3-5H,1-2H3/q+1

4333-62-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D4654)  1,3-Dimethylimidazolium Iodide  >98.0%(HPLC)(T)

  • 4333-62-4

  • 5g

  • 690.00CNY

  • Detail
  • TCI America

  • (D4654)  1,3-Dimethylimidazolium Iodide  >98.0%(HPLC)(T)

  • 4333-62-4

  • 25g

  • 2,390.00CNY

  • Detail

4333-62-4Synthetic route

1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

methyl iodide
74-88-4

methyl iodide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In dichloromethane for 1h;100%
In dichloromethane at 0℃; for 3h;99%
at 60℃;98%
(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)diiodo(pyridine)palladium

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)diiodo(pyridine)palladium

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 140℃; for 20h; Inert atmosphere; Schlenk technique; Sealed tube;100%
2-(Hydroxy-diphenyl-methyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide
111931-07-8

2-(Hydroxy-diphenyl-methyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

benzophenone
119-61-9

benzophenone

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With potassium carbonate In benzene at 60℃; for 2h; Product distribution; further reagent; var. time;A 96.6%
B n/a
bis(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)diiodonickel(II)
188776-79-6

bis(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)diiodonickel(II)

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With water In acetonitrile at 70℃; for 48h; Kinetics;88%
2-(1-hydroxy-1-phenyl-1-pentyl)-1-methyl-1H-imidazole
93031-50-6

2-(1-hydroxy-1-phenyl-1-pentyl)-1-methyl-1H-imidazole

A

phenyl butyl ketone
1009-14-9

phenyl butyl ketone

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With methyl iodide In ethyl acetate for 72h; Heating;A 86%
B 63%
2-(1-Hydroxy-1-phenyl-pentyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Hydroxy-1-phenyl-pentyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

phenyl butyl ketone
1009-14-9

phenyl butyl ketone

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In ethanol for 72h; Heating;A 86%
B 63%
With potassium carbonate In benzene Yield given;
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

methyl iodide
74-88-4

methyl iodide

butyl halide

butyl halide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In acetone for 5h; Reflux;84%
bis-(1,3-dihydro-1,3-dimethyl-2H-imidazol-2-ylidene)diiodopalladium

bis-(1,3-dihydro-1,3-dimethyl-2H-imidazol-2-ylidene)diiodopalladium

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 140℃; for 20h; Inert atmosphere; Schlenk technique; Sealed tube;80%
imidazolyl sodium
5587-42-8

imidazolyl sodium

methyl iodide
74-88-4

methyl iodide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In tetrahydrofuran for 4h; Reflux;67%
1H-imidazole
288-32-4

1H-imidazole

methyl iodide
74-88-4

methyl iodide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethyl-2-(1-hydroxyheptyl)-1H-imidazolium iodide
111931-06-7

1,3-dimethyl-2-(1-hydroxyheptyl)-1H-imidazolium iodide

A

heptanal
111-71-7

heptanal

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With sodium hydroxide; 6-aminohexanoic acid In benzene Yield given;
1,3-dimethyl-2-cyclohexyl-1-hydroxymethyl-1H-imidazolium iodide
111931-05-6

1,3-dimethyl-2-cyclohexyl-1-hydroxymethyl-1H-imidazolium iodide

A

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

B

cyclohexanecarbaldehyde
2043-61-0

cyclohexanecarbaldehyde

Conditions
ConditionsYield
With sodium hydroxide; 6-aminohexanoic acid In benzene
2-(1-Hydroxy-1-methyl-heptyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Hydroxy-1-methyl-heptyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

B

hexyl-methyl-ketone
111-13-7

hexyl-methyl-ketone

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-(1-Hydroxy-3,7-dimethyl-oct-6-enyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Hydroxy-3,7-dimethyl-oct-6-enyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

3,7-dimethyl-oct-6-enal
106-23-0, 26489-02-1

3,7-dimethyl-oct-6-enal

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With sodium hydroxide; 6-aminohexanoic acid In benzene at 80℃; for 5h; Yield given;
1,3-dimethyl-2-(1-hydroxy-1,2,3,4-tetrahydronaphth-1-yl)-1H-imidazolium iodide
111931-08-9

1,3-dimethyl-2-(1-hydroxy-1,2,3,4-tetrahydronaphth-1-yl)-1H-imidazolium iodide

A

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

B

3,4-dihydronaphthalene-1(2H)-one
529-34-0

3,4-dihydronaphthalene-1(2H)-one

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
1,3-dimethyl-2--1H-imidazolium iodide
111931-04-5

1,3-dimethyl-2--1H-imidazolium iodide

A

piperonal
120-57-0

piperonal

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-[1-Hydroxy-1-(7-methoxy-benzofuran-2-yl)-ethyl]-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-[1-Hydroxy-1-(7-methoxy-benzofuran-2-yl)-ethyl]-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

2-Acetyl-7-methoxybenzofuran
43071-52-9

2-Acetyl-7-methoxybenzofuran

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-(1-Cyclohexyl-1-hydroxy-2-phenyl-ethyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Cyclohexyl-1-hydroxy-2-phenyl-ethyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

1-cyclohexyl-2-phenylethanone
61259-29-8

1-cyclohexyl-2-phenylethanone

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-(1-tert-Butoxycarbonylmethyl-1-hydroxy-heptyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-tert-Butoxycarbonylmethyl-1-hydroxy-heptyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

3-oxo-nonanoic acid t-butyl ester
66696-99-9

3-oxo-nonanoic acid t-butyl ester

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-(1-Benzo[1,3]dioxol-5-yl-1-hydroxy-2-methoxycarbonyl-propyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Benzo[1,3]dioxol-5-yl-1-hydroxy-2-methoxycarbonyl-propyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

B

3-Benzo[1,3]dioxol-5-yl-2-methyl-3-oxo-propionic acid tert-butyl ester
111931-10-3

3-Benzo[1,3]dioxol-5-yl-2-methyl-3-oxo-propionic acid tert-butyl ester

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-(1-Benzo[1,3]dioxol-5-yl-2-tert-butoxycarbonyl-1-hydroxy-ethyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

2-(1-Benzo[1,3]dioxol-5-yl-2-tert-butoxycarbonyl-1-hydroxy-ethyl)-1,3-dimethyl-3H-imidazol-1-ium; iodide

A

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

B

3-Benzo[1,3]dioxol-5-yl-3-oxo-propionic acid tert-butyl ester
111931-09-0

3-Benzo[1,3]dioxol-5-yl-3-oxo-propionic acid tert-butyl ester

Conditions
ConditionsYield
With potassium carbonate In benzene Yield given;
2-((trimethylsilyl)methyl)-N,N'-dimethylimidazolium iodide
91631-72-0

2-((trimethylsilyl)methyl)-N,N'-dimethylimidazolium iodide

A

Trimethylsilanol
1066-40-6

Trimethylsilanol

B

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
With water at 25℃; Rate constant; Mechanism; pH=1.6;
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
Stage #1: 1-methyl-1H-imidazole With hydrogen iodide In water Cooling with ice;
Stage #2: carbonic acid dimethyl ester at 169.84℃; for 8h; Autoclave; Neat (no solvent);
4-methyl-4H-[1,2,4]triazole
10570-40-8

4-methyl-4H-[1,2,4]triazole

methyl iodide
74-88-4

methyl iodide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In acetonitrile for 36h; Reflux; Inert atmosphere; Schlenk technique;
(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(N-ethylethanamine)diiodopalladium

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(N-ethylethanamine)diiodopalladium

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 140℃; for 21h; Inert atmosphere; Schlenk technique; Sealed tube;95 %Chromat.
(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(diiodo)(pyridine)palladium

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(diiodo)(pyridine)palladium

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1,4-dioxane / 0.5 h / 50 °C / Inert atmosphere; Schlenk technique
2: N,N-dimethyl-formamide / 21 h / 140 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 1 h / 100 °C / Inert atmosphere; Schlenk technique; Sealed tube
2: N,N-dimethyl-formamide / 21 h / 140 °C / Inert atmosphere; Schlenk technique; Sealed tube
View Scheme
(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(diiodo)(pyridine)palladium

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(diiodo)(pyridine)palladium

triethylamine
121-44-8

triethylamine

trans-PdI2(1,3-dimethylimidazol-2-ylidene)2

trans-PdI2(1,3-dimethylimidazol-2-ylidene)2

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(N-ethylethanamine)diiodopalladium

(1,3-dimethyl-1,3-dihydro-2H-imidazol-2-ylidene)(N-ethylethanamine)diiodopalladium

C

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 100℃; for 1h; Inert atmosphere; Schlenk technique; Sealed tube;A 14 %Chromat.
B 22 %Chromat.
C 48 %Chromat.
chloro(1,5-cyclooctadiene)rhodium(I) dimer

chloro(1,5-cyclooctadiene)rhodium(I) dimer

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

chloro(η4-1,5-cyclooctadiene)(1-methyl-3-methylimidazole-2-ylidene)rhodium(I)

chloro(η4-1,5-cyclooctadiene)(1-methyl-3-methylimidazole-2-ylidene)rhodium(I)

Conditions
ConditionsYield
With potassium carbonate In toluene imidazolium salt dissolved in toluene; Rh complex and K2CO3 added in oneportion; stirred at 70°C for 2 h; solvent removed; purified by column chromy. (CH2Cl2); solid dried under reduced pressure;100%
Stage #1: 1,3-dimethylimidazolim iodide With silver(l) oxide In dichloromethane at 20℃; for 1h; Schlenk technique; Inert atmosphere; Darkness;
Stage #2: chloro(1,5-cyclooctadiene)rhodium(I) dimer In dichloromethane at 20℃; Schlenk technique; Inert atmosphere;
55%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium thiocyanate
359399-82-9

1,3-dimethylimidazolium thiocyanate

Conditions
ConditionsYield
With Amberlist A-26 SCN(-) form In methanol Ionic liquid;100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium nitrate
941584-21-0

1,3-dimethylimidazolium nitrate

Conditions
ConditionsYield
With Amberlist A-26 NO3(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (NO3- form) In methanol100%
With silver nitrate In dichloromethane at 20℃; for 0.333333h; Darkness;82%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

[mmim]H2PO4
1098281-76-5

[mmim]H2PO4

Conditions
ConditionsYield
With Amberlist A-26 H2PO4(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (H2PO4- form) In methanol100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium chloride
79917-88-7

1,3-dimethylimidazolium chloride

Conditions
ConditionsYield
With Amberlist A-26 Cl(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (Cl- form) In methanol100%
With hydrogenchloride In water at 100℃; pH=7;93%
With ion exchange resin (Aldrich, Dorwex 1 x 4 chloride form)
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium perchlorate

1,3-dimethylimidazolium perchlorate

Conditions
ConditionsYield
With Amberlist A-26 ClO4(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (ClO4- form) In methanol100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1-methyl-3-methylimidazol-3-ium tetrafluoroborate

1-methyl-3-methylimidazol-3-ium tetrafluoroborate

Conditions
ConditionsYield
With Amberlist A-26 BF4(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (BF4- form) In methanol100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1-methyl-3-methylimidazolium hydrogen sulfate

1-methyl-3-methylimidazolium hydrogen sulfate

Conditions
ConditionsYield
With Amberlist A-26 HSO4(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (HSO4- form) In methanol100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethyl-1H-imidazol-3-ium hexafluorophosphate

1,3-dimethyl-1H-imidazol-3-ium hexafluorophosphate

Conditions
ConditionsYield
With Amberlist A-26 PF6(-) form In methanol Ionic liquid;100%
With Amberlyst A-26 (PF6- form) In methanol100%
With potassium hexafluorophosphate at 20℃; for 4h;83.5%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Amberlist A-26 (S)-lactate(-) form

Amberlist A-26 (S)-lactate(-) form

[mmim](S)-lactate
1382354-64-4

[mmim](S)-lactate

Conditions
ConditionsYield
In methanol Ionic liquid; solid phase reaction;100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Amberlist A-26 AcO(-) form

Amberlist A-26 AcO(-) form

1,3-dimethyl-1H-imidazol-3-ium acetate
78643-53-5

1,3-dimethyl-1H-imidazol-3-ium acetate

Conditions
ConditionsYield
In methanol Ionic liquid; solid phase reaction;100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Amberlist A-26 Bu2PO4(-) form

Amberlist A-26 Bu2PO4(-) form

[mmim]Bu2PO4
1382354-65-5

[mmim]Bu2PO4

Conditions
ConditionsYield
In methanol Ionic liquid; solid phase reaction;100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

Amberlist A-26 CF3SO3(-) form

Amberlist A-26 CF3SO3(-) form

3-methyl-1-methylimidazolium trifluoromethanesulfonate
121091-30-3

3-methyl-1-methylimidazolium trifluoromethanesulfonate

Conditions
ConditionsYield
In methanol Ionic liquid; solid phase reaction;100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium fluoride

1,3-dimethylimidazolium fluoride

Conditions
ConditionsYield
With silver fluoride In water at 20℃; for 2h;100%
With hydrogen fluoride In water at 50 - 100℃; for 3h; Temperature;4.90 g
With silver fluoride In water at 20℃; for 2h;
CF3O3S(1-)*H(1+)*H3N
38542-94-8

CF3O3S(1-)*H(1+)*H3N

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

3-methyl-1-methylimidazolium trifluoromethanesulfonate
121091-30-3

3-methyl-1-methylimidazolium trifluoromethanesulfonate

Conditions
ConditionsYield
Stage #1: CF3O3S(1-)*H(1+)*H3N With Amberlyst A-26 (OH- form) In water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
100%
L-Lactic acid
79-33-4

L-Lactic acid

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

[mmim](S)-lactate
1382354-64-4

[mmim](S)-lactate

Conditions
ConditionsYield
Stage #1: L-Lactic acid With Amberlyst A-26 (OH- form) In methanol; water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
100%
ammonium acetate
631-61-8

ammonium acetate

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethyl-1H-imidazol-3-ium acetate
78643-53-5

1,3-dimethyl-1H-imidazol-3-ium acetate

Conditions
ConditionsYield
Stage #1: ammonium acetate With Amberlyst A-26 (OH- form) In water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

ammonium thiocyanate

ammonium thiocyanate

1,3-dimethylimidazolium thiocyanate
359399-82-9

1,3-dimethylimidazolium thiocyanate

Conditions
ConditionsYield
Stage #1: ammonium thiocyanate With Amberlyst A-26 (OH- form) In water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
100%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

dibutyl phosphate
107-66-4

dibutyl phosphate

[mmim]Bu2PO4
1382354-65-5

[mmim]Bu2PO4

Conditions
ConditionsYield
Stage #1: dibutyl phosphate With Amberlyst A-26 (OH- form) In methanol; water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
100%
potassium cyanate
590-28-3

potassium cyanate

cobalt(II) chloride hexahydrate

cobalt(II) chloride hexahydrate

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

{[1,3-dimethylimidazolium ]2[Co(NCO)4]}

{[1,3-dimethylimidazolium ]2[Co(NCO)4]}

Conditions
ConditionsYield
In water98%
(dicarbonyl)(cyclopentadienyl)(trimethylphosphine)tungsten hydride
98757-38-1, 31852-08-1, 31811-36-6

(dicarbonyl)(cyclopentadienyl)(trimethylphosphine)tungsten hydride

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

[1,3-dimethylimidazolium][(C5H5)W(CO)2(P(CH3)3)]
1357392-14-3

[1,3-dimethylimidazolium][(C5H5)W(CO)2(P(CH3)3)]

Conditions
ConditionsYield
With KH In tetrahydrofuran; diethyl ether byproducts: KI; (N2); Schlenk technique; suspn. of imidazolium salt and KH in THF was stirred for 4 h; Et2O was added; filtered; added dropwise to soln. of W complex in Et2O; cooled to -35°C for 1 h; mother liquor removed; residue washed (Et2O); dried (vac.); elem. anal.;97%
tris(triphenylphosphine)ruthenium(II) chloride
15529-49-4, 41756-81-4

tris(triphenylphosphine)ruthenium(II) chloride

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

[Ru(1,3-dimethylimidazol)4Cl2]

[Ru(1,3-dimethylimidazol)4Cl2]

Conditions
ConditionsYield
Stage #1: 1,3-dimethylimidazolim iodide With potassium hydride In tetrahydrofuran; diethyl ether for 1.5h; Schlenk technique; Glovebox;
Stage #2: tris(triphenylphosphine)ruthenium(II) chloride In tetrahydrofuran; diethyl ether Schlenk technique; Glovebox;
97%
2K(1+)*H(1+)*2Cr*6CO*3OH(1-)=K2H{Cr2(CO)6(OH)3}

2K(1+)*H(1+)*2Cr*6CO*3OH(1-)=K2H{Cr2(CO)6(OH)3}

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

cis-(Cr(CO)4(C3HN2CH3)2)

cis-(Cr(CO)4(C3HN2CH3)2)

Conditions
ConditionsYield
In further solvent(s) byproducts: H2O, OH(1-), H2; Dissolving of starting compds. with exclusion of air in ethylene glycol monomethyl ether, heating (160°C).; Removal of solvent after 0.5 h in vac., further heating (170°C, 0.5 h), and then cooling. Satn. (N2) of grey-green react. mixt., extn. (THF), evapn. of exts. in vac., washing of residue (H2O/CH3OH), recrystn. (THF/CH3OH).;96%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

silver(l) oxide
20667-12-3

silver(l) oxide

(1,3-dimethyl-1H-imidazol-2(3H)-ylidene)silver(I) iodide

(1,3-dimethyl-1H-imidazol-2(3H)-ylidene)silver(I) iodide

Conditions
ConditionsYield
In dichloromethane (under N2, Schlenk); ligand, Ag2O and CH2Cl2 stirred in vessel at 50°C for 10 h, cooled to ambient temp.; filtered, solvent removed under reduced pressure;95%
In dichloromethane at 55℃; Inert atmosphere; Autoclave;77%
In dichloromethane at 20℃; for 3h; Inert atmosphere; Darkness;
In acetonitrile at 20℃; for 3h; Schlenk technique; Darkness;
In dichloromethane for 4h; Schlenk technique; Inert atmosphere; Darkness;
silver dinitromethanide
12281-47-9

silver dinitromethanide

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolium dinitromethanide
1260364-77-9

1,3-dimethylimidazolium dinitromethanide

Conditions
ConditionsYield
In methanol for 24h;95%
methanesulfonic acid
75-75-2

methanesulfonic acid

1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

1,3-dimethylimidazolinium methanesulfonate

1,3-dimethylimidazolinium methanesulfonate

Conditions
ConditionsYield
Stage #1: methanesulfonic acid With Amberlyst A-26 (OH- form) In methanol; water at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
95%
1,3-dimethylimidazolim iodide
4333-62-4

1,3-dimethylimidazolim iodide

benzoic acid
65-85-0

benzoic acid

[mmim]OBz

[mmim]OBz

Conditions
ConditionsYield
Stage #1: benzoic acid With Amberlyst A-26 (OH- form) In tetrahydrofuran; methanol; water; acetonitrile at 20℃;
Stage #2: 1,3-dimethylimidazolim iodide In methanol
95%

4333-62-4Relevant academic research and scientific papers

Experimental and theoretical studies on imidazolium ionic liquid-promoted conversion of fructose to 5-hydroxymethylfurfural

Li, Yu-Nong,He, Liang-Nian,Yang, Zhen-Zhen,Liu, An-Hua,Yu, Bing,Luan, Chao-Ran,Wang, Jin-Quan

, p. 2752 - 2758,7 (2012)

A combined experimental and computational study on the imidazolium ionic liquid-promoted conversion of fructose to 5-hydroxymethylfurfural (HMF) was performed. In particular, 1-butyl-3-methyl-imidazolium bromide (BMImBr) was found to be unexpectedly effective for conversion of fructose into HMF without utilizing any other additive or catalyst. Under the optimized conditions, nearly 100% conversion of fructose with a 95% yield of HMF could be obtained. In addition, BMImBr could be easily recovered and reused over 6 times without significant loss of activity. This protocol represents a simple, recyclable and environmentally friendly pathway for HMF production. Furthermore, the detailed mechanism of the BMImBr-promoted conversion of fructose into HMF was also studied through an in situ FT-IR technique, NMR and density functional theory calculations, and demonstrated that the hydrogen bond interaction between BMImBr and fructose could play an important role in promoting the dehydration of fructose. This work also provides further understanding at the molecular level of the reaction process for ionic liquid-promoted conversion of fructose to HMF.

Photochemical Reduction of CO2 Using 1,3-Dimethylimidazolylidene

Denning, Derek M.,Thum, Matthew D.,Falvey, Daniel E.

, p. 4152 - 4155 (2015)

Product analysis along with fluorescence quenching and laser flash photolysis experiments demonstrate that it is possible to effect a net photochemical reduction of CO2 through photolysis of an excited state donor in the presence of 1,3-dimethylimidazolium-2-carboxylate.

Imidazolium bromide-based ionic liquid assisted improved activity of trypsin in cationic reverse micelles

Debnath, Sisir,Das, Dibyendu,Dutta, Sounak,Das, Prasanta Kumar

, p. 4080 - 4086 (2010)

The present work reports the imidazolium-based ionic liquids (ILs) assisted enhancement in activity of water-pool solubilized enzyme trypsin in cationic reverse micelles of CTAB. A set of imidazolium ILs (1-alkyl-3-methyl imidazolium bromides) were prepared with varying lengths of their side armwhich results in the differential location of these organic salts in the reverse micelles. The different ILs offered varied activating effects on the biocatalyst. The activity of trypsin improved 30-300% in the presence of 0.1-10 mM of different ILs in reverse micelles of CTAB. Trypsin showed 300% (4-fold) increment in its activity in the presence of IL2 (1-ethyl-3-methyl imidazoliumbromide,EMIMBr) compared to that observed in the absence of IL in CTAB reverse micelles. The imidazolium moiety of the IL, resembling the histidine amino acid component of the catalytic triad of hydrolases and itsBr- counterion, presumably increases the nucleophilicity of water in the vicinity of the enzyme by forming a hydrogen bond that facilitates the enzyme-catalyzed hydrolysis of the ester.However, the ILs with increasing amphiphilic character had little to no effect on the activity of trypsin due to their increased distance from the biocatalyst, as they tend to get localized toward the interfacial region of the aggregates. Dynamic light scattering experimentationwas carried out in the presence of ILs to find a possible correlation between the trypsin activity and the size of the aggregates. In concurrencewith the observed highest activity in the presence of IL2, the circular dichroism (CD) spectrum of trypsin in CTAB reverse micelles doped with IL 2 exhibited the lowest mean residue ellipticity (MRE), which is closest to that of the native protein in aqueous buffer.

Photochemistry of imidazolium cations. Water addition to methylimidazolium ring induced by UV radiation in aqueous solution

Sarmiento, Gabriela P.,Zelcer, Andrés,Espinosa, Mariela S.,Babay, Paola A.,Mirenda, Martin

, p. 155 - 163 (2016)

The UV-C induced photoaddition of water to N-alkyl-N′-methylimidazolium cations was studied. The main photoreaction products exhibit chemical additions of a proton and a hydroxyl group to either positions 4 or 5 of the imidazolium ring. For unsymmetrical imidazolium cations, two positional isomers were obtained as products. In these cases, the most abundant isomer is the one in which the hydroxyl group adds at the side of the ring having the longer alkyl substituent. Experiments performed in D2O solutions reveal that the additions of proton and hydroxyl group never take place at the same carbon atom, in a reaction that produces equal amounts of diastereoisomers. Moreover, the formation of diastereoisomers at equal proportions suggests that the reaction proceeds in an unconcerted fashion.

Expanding the catalytic activity of nucleophilic N-heterocyclic carbenes for transesterification reactions

Nyce, Gregory W.,Lamboy, Jorge A.,Connor, Eric F.,Waymouth, Robert M.,Hedrick, James L.

, p. 3587 - 3590 (2002)

(graph presented) Currently, there is a renewed interest in reactions that are catalyzed by organic compounds. Typical organic catalysts for acylation or transesterification reactions are based on either nucleophilic tertiary amines or phosphines. This communication discusses the use of nucleophilic N-heterocyclic carbenes as efficient transesterification catalysts. These relatively unexplored and highly versatile organic catalysts were found to be mild, selective, and more active than traditional organic nucleophiles.

New room-temperature ionic liquids with C2-symmetrical imidazolium cations

Dzyuba,Bartsch

, p. 1466 - 1467 (2001)

New 1,3-dialkylimidazolium hexafluorophosphates with two butyl, pentyl, octyl, nonyl or decyl groups are room temperature ionic liquids.

Synthesis of biphenyl-4,4′-diylbis(naphthalene-1-ylmethanone) via carbonylative coupling

Song, Ju Hyun

, p. 3031 - 3034 (2015)

More recently, an interest has been developed in three component carbonylation reactions, such as the carbonylative Suzuki, carbonylative Sonogashira and carbonylative Heck reactions, which allow for a significant increase in molecular complexity. To develop a luminescent material with high colour purity, luminous efficiency and stability, we synthesized diketone by carbonylative Suzuki coupling in the presence of Pd(NHC)(NHC=N-heterocyclic carbene) complex as the catalyst. Carbonylative coupling of 4,4′-diiodobiphenyl and naphthalene-1-ylboronic acid was investigated to study the catalytic ability of Pd(NHC) complex. Reactions were carried out using both CO and metal carbonyls. bis(1,3-Dihydro-1,3-dimethyl-2H-imidazol-2-ylidene)diiodopalladium was used as the catalytic complex. Reaction products biphenyl-4,4′-diylbis(naphthalene-1-ylmethanone) 3 and (4′-iodobiphenyl-4yl)(naphthalene-1-yl)methanone 4 were obtained as a result of CO insertion into the palladium(II)-aryl bond. However, when pyridine-4-ylboronic acid was used in place of naphthalene-1-ylboronic acid as the starting reagent, synthetic reaction yielding 3 and 4 were found.

Electrochemical and physicochemical properties of redox ionic liquids using electroactive anions: Influence of alkylimidazolium chain length

Xie, Han Jin,Gélinas, Bruno,Rochefort, Dominic

, p. 283 - 289 (2016)

Ferrocenylsulfonyl(trifluoromethylsulfonyl)imide [FcNTf] is reported as a redox anionic species used to obtain an electroactive ionic liquid with a typical alkylimidazolium cation. Here, several of these redox ionic liquids (RILs) were prepared by combining FcNTf with alkylimidazolium cations in order to understand the influence of symmetry and alkyl chain length on the RIL system. The physicochemical and electrochemical properties are characterized for [CxCyIm][FcNTf], where x and y were varied between 1 and 8, both in the pure, undiluted state and in solutions of acetonitrile. In pure form, the ionic conductivity of [CxCyIm][FcNTf] was found to range between 0.22 and 0.42 mS cm-1 at 60 °C, and the alkyl chain length was found to have a similar effect on viscosity as in conventional imidazolium-NTf2 ionic liquids. While an increase in alkyl chain length increases viscosity and decreases mass transport, it was found to have no effect on the redox potential of the ferrocene center. The cyclic voltammetry of [CxCyIm][FcNTf] solutions diluted in acetonitrile exhibited behavior which depends on concentration and on the presence of a supporting electrolyte. At concentrations above 50 wt.% and in the absence of any supporting electrolyte, the electroactive anion was found to deposit as a dense film on the electrode upon oxidation. This behavior is linked to formation of Fc+NTf- zwitterions, which accumulates in the double-layer and precipitates on the electrode surface. This study also investigates the electrochemical properties of film deposition.

A new method for improving the ion conductivity of anion exchange membranes by using TiO2 nanoparticles coated with ionic liquid

Chu, Yuhao,Chen, Yuenan,Chen, Nanjun,Wang, Fanghui,Zhu, Hong

, p. 96768 - 96777 (2016)

Recently a new method for increasing the ion conductivity of anion exchange membranes (AEM) was developed based on the novel materials ionic liquids (ILs). We mixed the ILs into the membrane directly instead of immobilizing onto the polymer backbone as in the traditional way. Nano-TiO2 was introduced to stabilize the ILs in the membrane. The ILs were immobilized by the nano-TiO2, acting as the "active sites" in the membrane, to enhance the mobility of the hydroxyl groups so as to increase the ion conductivity. Both pure ILs composite membranes and ILs-TiO2 composite membranes were synthesized, and their properties were compared. 1H nuclear magnetic resonance spectroscopy and Fourier transform infrared spectroscopy were used to analyze the structures of the composite membranes. The mechanical properties, thermal stabilities, ion conductivities, water uptakes, swelling ratios, and ion exchange capacities of the membranes were investigated. The interaction between the TiO2 and ionic liquids was confirmed by X-ray diffraction. The stability of the ILs in the membrane was measured comprehensively. All these results show that this novel method is effective and promising for AEM applications.

Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes

Gothe, Yvonne,Marzo, Tiziano,Messori, Luigi,Metzler-Nolte, Nils

, p. 12487 - 12494 (2016)

A series of structurally related mono- and bis-NHC–iridium(I) (NHC: N-heterocyclic carbene) complexes have been investigated for their suitability as potential anticancer drugs. Their spectral behaviour in aqueous buffers under physiological-like conditions and their cytotoxicity against the cancer cell lines MCF-7 and HT-29 are reported. Notably, almost all complexes exhibit significant cytotoxic effects towards both cancer cell lines. In general, the cationic bis-carbene complexes show higher stability and greater anticancer activity than their neutral mono-carbene analogues with IC50values in the high nanomolar range. Furthermore, to gain initial mechanistic insight, the interactions of these iridium(I)–NHC complexes with two model proteins, namely lysozyme and cytochrome c, were explored by HR-ESI-MS analyses. The different protein metalation patterns of the complexes can be roughly classified into two distinct groups. Those interactions give us a first idea about the possible mechanism of action of this class of compounds. Overall, our findings show that iridium(I)–NHC complexes represent very interesting candidates for further development as new metal-based anticancer drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4333-62-4